Our Pricing

Understanding and Managing Tiredness When Starting Mounjaro

Published on: June 03, 2026

If you're experiencing mounjaro tiredness uk treatment concerns, you're not alone—fatigue is a recognised side effect reported by some patients during the initial weeks of tirzepatide therapy. At Cured Pharmacy, our UK-registered clinical team helps patients understand what to expect when beginning Mounjaro treatment and provides evidence-based guidance for managing side effects effectively.

Why Does Mounjaro Cause Tiredness in Some Patients?

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that fundamentally changes how your body regulates appetite, blood sugar, and energy metabolism [1]. When you begin treatment, your body undergoes significant metabolic adjustments that can temporarily affect energy levels.

The most common reason for tiredness during early Mounjaro treatment relates to reduced caloric intake. As tirzepatide suppresses appetite and slows gastric emptying, many patients naturally consume 20-30% fewer calories than before [1]. This caloric deficit, whilst essential for weight loss, can initially leave you feeling fatigued until your body adapts to its new energy balance.

Additionally, the medication's effect on blood glucose regulation may contribute to fatigue in some individuals. Tirzepatide improves insulin sensitivity and reduces post-meal glucose spikes, which can alter the energy patterns your body has grown accustomed to [2]. These metabolic shifts typically stabilise within 2-4 weeks as your system adjusts to the treatment.

How Long Does Mounjaro Tiredness Typically Last?

In clinical experience, tiredness associated with starting Mounjaro is usually temporary and most pronounced during the first 2-4 weeks of treatment. The SURPASS clinical trial programme, which included over 5,000 participants, documented fatigue as a side effect in approximately 5-8% of patients, with most cases resolving as the body adapted to the medication [1][3].

The duration and severity of tiredness often correlate with your starting dose and how quickly you titrate upward. Mounjaro treatment begins with a 2.5mg weekly dose specifically to allow your body time to adjust before increasing to therapeutic levels. Patients who follow the recommended dose escalation schedule typically experience fewer and milder side effects, including fatigue [3].

If tiredness persists beyond 4-6 weeks or significantly impacts your daily functioning, this warrants discussion with your UK prescriber. Persistent fatigue may indicate that your dose needs adjustment, that you're not consuming adequate nutrition, or that other factors unrelated to Mounjaro require investigation.

Individual Variation in Side Effect Duration

It's important to recognise that every patient responds differently to tirzepatide therapy. Factors including your baseline metabolic health, existing medications, sleep quality, and nutritional habits all influence how your body adapts to Mounjaro. Some patients report minimal fatigue, whilst others may need additional support strategies during the adjustment period.

Evidence-Based Strategies to Manage Tiredness on Mounjaro

The most effective approach to managing mounjaro tiredness uk treatment involves ensuring adequate nutritional intake despite reduced appetite. Focus on nutrient-dense foods that provide sustained energy—lean proteins, complex carbohydrates, healthy fats, and plenty of vegetables. Even when you're not feeling hungry, aim for regular small meals to maintain stable blood glucose and energy levels throughout the day.

Hydration plays a crucial role in combating fatigue during Mounjaro treatment. The medication can increase fluid requirements, and even mild dehydration exacerbates tiredness. Target at least 2-3 litres of water daily, increasing this amount if you're physically active or experiencing other gastrointestinal side effects like nausea.

Strategic timing of your injection can also help minimise daytime fatigue. Many patients find that administering their weekly Mounjaro dose in the evening allows any initial tiredness to occur during sleep hours. Your UK prescriber can advise on the optimal injection schedule based on your individual response pattern.

When to Seek Clinical Advice About Fatigue

Contact your prescriber if you experience severe or worsening tiredness, fatigue accompanied by dizziness or confusion, inability to perform daily activities, or tiredness that persists beyond 6 weeks of treatment. These symptoms may require dose adjustment or investigation of other contributing factors unrelated to your Mounjaro therapy.

Nutritional Considerations When Starting Mounjaro Treatment

Maintaining adequate protein intake is particularly important for preserving energy levels and lean muscle mass during weight loss with Mounjaro. Aim for 1.2-1.6 grams of protein per kilogram of your target body weight, distributed across the day [4]. High-quality protein sources like eggs, Greek yoghurt, lean meats, fish, and legumes provide sustained energy and help prevent the muscle loss that can worsen fatigue.

Micronutrient deficiencies can significantly contribute to tiredness, especially when overall food intake decreases. Patients on Mounjaro should pay particular attention to iron, vitamin B12, vitamin D, and magnesium levels. A daily multivitamin formulated for adults managing weight loss may help bridge nutritional gaps, though whole food sources remain preferable where possible.

Complex carbohydrates provide steady glucose release that supports stable energy levels throughout the day. Contrary to popular low-carb approaches, moderate amounts of whole grains, sweet potatoes, oats, and fruits can actually help combat fatigue during Mounjaro treatment by preventing the energy crashes associated with very low carbohydrate intake.

Comparing Tiredness Across Different Weight Loss Treatments

Fatigue as a side effect is not unique to Mounjaro—it occurs with varying frequency across different weight loss medications available in the UK. Understanding these patterns can help set realistic expectations regardless of which treatment your prescriber recommends.

Wegovy (semaglutide), another GLP-1 receptor agonist, shows similar tiredness rates to Mounjaro in clinical trials, with approximately 5-7% of patients reporting fatigue during the initial treatment phase [5]. The mechanisms are comparable, as both medications reduce appetite and alter metabolic patterns. Saxenda (liraglutide), administered daily rather than weekly, may produce more consistent energy levels for some patients due to its shorter half-life and daily dosing pattern.

In contrast, Orlistat-based treatments like Xenical work through a completely different mechanism—blocking fat absorption in the digestive system—and typically do not cause tiredness as a direct side effect. However, the gastrointestinal effects of orlistat can indirectly impact energy if they disrupt sleep or nutrient absorption. Your UK prescriber will consider your individual tolerance for different side effect profiles when recommending the most suitable treatment.

Choosing Treatment Based on Side Effect Profile

If you have concerns about managing tiredness alongside work or family commitments, discuss these openly during your clinical consultation at Cured Pharmacy. Your prescriber can help weigh the superior weight loss efficacy of GLP-1 treatments against your lifestyle requirements and may suggest starting with lower doses or alternative medications if fatigue would significantly impact your quality of life.

How to Begin Mounjaro Treatment at Cured Pharmacy

Starting Mounjaro treatment at Cured Pharmacy begins with a comprehensive online clinical assessment completed by a UK-registered prescriber. This consultation evaluates your medical history, current medications, weight loss goals, and any conditions that might affect treatment suitability. The assessment typically takes under 3 minutes to complete and ensures Mounjaro is safe and appropriate for your individual circumstances.

If approved, your prescription is dispensed by our UK-registered pharmacy team under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). Mounjaro is supplied in genuine KwikPen injectors, with clear instructions for administration and dose escalation. Your initial prescription begins at 2.5mg weekly, with planned increases every 4 weeks up to your target maintenance dose, subject to tolerability and clinical response.

Cured Pharmacy provides Mounjaro from £124.99, with transparent pricing displayed before you complete your consultation—no hidden fees or surprise charges. All medications are delivered in 100% discreet packaging with next-day delivery options available across the UK. Ongoing support from our clinical team ensures any side effects, including tiredness, are monitored and managed effectively throughout your treatment journey.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
4. Pasiakos, S. M., Cao, J. J., Margolis, L. M., et al. (2013). Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. The FASEB Journal, 27(9), 3837–3847. https://doi.org/10.1096/fj.13-230227 [accessed 13 August 2026]
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and side effects should be discussed with your clinical team.